Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?

Published Online: Sep 28, 2019

Page range: 154 - 159

Received: Jan 08, 2019

Accepted: Mar 27, 2019

DOI: https://doi.org/10.2478/cipms-2019-0028

Keywords

ovarian cancer, peritoneal carcinomatosis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, p53, BRCA 1

© 2019 Roman Yarema et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.